Source: Annual Congress 2001 - COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. D. Bateman, R. Hodder, M. Miravitlles, A. Lee, L. Towse, C. Serby (Cape Town, South Africa; Ottawa, Canada; Barcelona, Spain; Bracknell, United Kingdom; Ridgefield, United States Of America). A comparative trial of tiotropium, salmeterol and placebo: health-related quality of life. Eur Respir J 2001; 16: Suppl. 31, 287

Member's Comments

No comment yet.

Related content which might interest you: Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium Source: Annual Congress 2009 - New bronchodilators Year: 2009 Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD patients: a 52-week study Source: Annual Congress 2009 - New bronchodilators Year: 2009 NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Health-related quality of life and asthma control in patients treated with budesonide and formoterol in a single inhaler Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001 A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis Source: Annual Congress 2004 - Bronchiectasis Year: 2004 A multicenter, open-label, randomized comparison of the effects of HFA-BDP and FP on asthmatic inflammation of lower airways and health-related quality of life Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007 Observational study of salmeterol/fluticasone combination on quality of life in children Source: Eur Respir J 2005; 26: Suppl. 49, 158s Year: 2005 Health-related quality of life (HRQL) and use of formoterol in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 55s Year: 2001 Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial Source: ERJ Open Res, 7 (3) 00255-2021; 10.1183/23120541.00255-2021 Year: 2021 Salmeterol/fluticasone (seretide, S/F) used as needed improves health-related quality of life in asthmatic adolescents uncontrolled with ICS receiving inhaled short-acting β2 agonists (SAB2A) Source: Eur Respir J 2004; 24: Suppl. 48, 380s Year: 2004 Indacaterol once-daily improves day and night-time symptom control in COPD patients: a 26-week study versus placebo and tiotropium Source: Annual Congress 2009 - New bronchodilators Year: 2009 The impact of salmeterol/fluticasone propionate combination product on asthma-related quality of life Source: Eur Respir J 2001; 18: Suppl. 33, 517s Year: 2001 Montelukast versus budesonide on quality of life in asthmatics subjects Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002 Effect of a self-management programme on health-related quality of life in COPD patients: a randomised controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002 Safety and tolerability of indacaterol once-daily in COPD patients versus placebo and tiotropium: a 26-week study Source: Annual Congress 2009 - New bronchodilators Year: 2009 Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial Source: Eur Respir J 2003; 22: 787-794 Year: 2003 Achieving guideline-based asthma control: does the patient benefit? Source: Eur Respir J 2002; 20: 588-596 Year: 2002 Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001 Single inhaler triple therapy in patients with COPD: response rates in health-related quality of life in the IMPACT Trial Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018